p.61 抽出テキスト

82 Reeh J, Therming CB, Heitmann M, et al. Prediction of obstructive

coronary artery disease and prognosis in patients with suspected stable angina. Eur Heart J 2019; 40: 1426-1435. PMID: 30561616 83. Gitto M, Gentile F, Nowbar AN, et al. Gender-related differences in clinical presentation and angiographic findings in patients with Ischemia and No Obstructive Coronary Artery disease (INOCA): A single-center observational registry. Int J Angiol 2020; 29: 250-255. PMID: 33268976 84. von Mering GO, Arant CB, Wessel TR, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: Results from the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109: 722-725. PMID: 14970106 85. Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: A report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 2009; 169: 843-850. PMID: 19433695 86. Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010; 55: 2825-2832. PMID: 20579539 87. Sharaf B, Wood T, Shaw L, et al. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) angiographic core laboratory. Am Heart J 2013; 166: 134-141. PMID: 23816032 88. Murthy VL, Naya M, Taqueti VR, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 2014; 129: 2518-2527. PMID: 24787469 89. Radico F, Zimarino M, Fulgenzi F, et al. Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis. Eur Heart J 2018; 39: 2135-2146. PMID: 29688324 90. AlBadri A, Bairey Merz CN, Johnson BD, et al. Impact of abnormal coronary reactivity on long-term clinical outcomes in women. J Am Coll Cardiol 2019; 73: 684-693. PMID: 30765035 91. Lanza GA, Crea F, Kaski JC. Clinical outcomes in patients with primary stable microvascular angina: is the jury still out? Eur Heart J Qual Care Clin Outcomes 2019; 5: 283-291. PMID: 31168622 92. Al-Badri A, Tahhan AS, Sabbak N, et al. Soluble urokinase-type plasminogen activator receptor and high-sensitivity troponin levels predict outcomes in nonobstructive coronary artery disease. J Am Heart Assoc 2020; 9: e015515. PMID: 32301366 93. Schroder J, Michelsen MM, Mygind ND, et al. Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study. Eur Heart J 2021; 42: 228-239. PMID: 33477168 94. Maddox TM, Stanislawski MA, Grunwald GK, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA 2014; 312: 1754-1763. PMID: 25369489 95. Lee SH, Shin D, Lee JM, et al. Clinical relevance of ischemia with nonobstructive coronary arteries according to coronary microvascular dysfunction. J Am Heart Assoc 2022; 11: e025171. PMID: 35475358 96. Jespersen L, Abildstrøm SZ, Hvelplund A, et al. Symptoms of angina pectoris increase the probability of disability pension and premature exit from the workforce even in the absence of obstructive coronary artery disease. Eur Heart J 2013; 34: 3294-3303. PMID: 24071763 97. Johnson BD, Shaw LJ, Buchthal SD, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109: 2993-2999. PMID: 15197152 98. Shaw LJ, Merz CN, Pepine CJ, et al. Women’s Ischemia Syndrome Evaluation (WISE) Investigators. The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women’s Ischemia Syndrome Evaluation. Circulation 2006; 114: 894-904. PMID: 16923752 99. Jespersen L, Abildstrom SZ, Hvelplund A, et al. Burden of hospital admission and repeat angiography in angina pectoris patients with and without coronary artery disease: a registry-based cohort study. PLoS One 2014; 9: e93170. PMID: 24705387 100. Schumann CL, Mathew RC, Dean JL, et al. Functional and economic impact of INOCA and influence of coronary microvascular dysfunction. JACC Cardiovasc Imaging 2021; 14: 1369-1379. PMID: 33865784 101. Kunadian V, Chieffo A, Camici PG, et al. An EAPCI Expert Consen- sus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 2020; 41: 3504-3520. PMID: 32626906 102. Perera D, Berry C, Hoole SP, et al. Invasive coronary physiology in

patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership. Heart 2022; 109: 88-95. PMID: 35318254 103. Mohri M, Koyanagi M, Egashira K, et al. Angina pectoris caused by coronary microvascular spasm. Lancet 1998; 351: 1165-1169. PMID: 9643687 104. Sun H, Mohri M, Shimokawa H, et al. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 2002; 39: 847-851. PMID: 11869851 105. Ohba K, Sugiyama S, Sumida H, et al. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease. J Am Heart Assoc 2012; 1: e002485. PMID: 23316292 106. Sato K, Kaikita K, Nakayama N, et al. Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and longterm prognosis in 873 consecutive patients with coronary spasm: Analysis of a single-center study over 20 years. J Am Heart Assoc 2013; 2: e000227. PMID: 23858100 107. Kaikita K, Ishii M, Sato K, et al. Determinants of myocardial lactate production during acetylcholine provocation test in patients with coronary spasm. J Am Heart Assoc 2015; 4: e002387. PMID: 26656861 108. Akasaka T, Hokimoto S, Sueta D, et al. Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder. Am J Physiol Heart Circ Physiol 2016; 310: H1494-H1500. PMID: 26993229 109. Hokimoto S, Tabata N, Yamanaga K, et al. Prevalence of coronary macro- and micro-vascular dysfunctions after drug-eluting stent implantation without in-stent restenosis. Int J Cardiol 2016; 222: 185- 194. PMID: 27497093 110. Takahashi J, Suda A, Yasuda S, et al. Measurement of myocardial lactate production for diagnosis of coronary microvascular spasm. J Vis Exp 2021; 175: e62558. PMID: 34605803 111. Shimokawa H. 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalitiess from bench to bedside. Eur Heart J 2014; 35: 3180-3193. PMID: 25354517 112. Nishimiya K, Suda A, Fukui K, et al. Prognostic links between OCT-delineated coronary morphologies and coronary functional abnormalities in patients with INOCA. JACC Cardiovasc Interv 2021; 14: 606-618. PMID: 33736768 113. Pirozzolo G, Martínez Pereyra V, Hubert A, et al. Coronary artery spasm and impaired myocardial perfusion in patients with ANOCA: Predictors from a multimodality study using stress CMR and acetylcholine testing. Int J Cardiol 2021; 343: 5-11. PMID: 34499976 114. Montone RA, Rinaldi R, Del Buono MG, et al. Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries. EuroIntervention 2022; 18: e666-e676. PMID: 35377315 115. Seitz A, Martínez Pereyra V, Sechtem U, et al. Update on coronary artery spasm 2022 – A narrative review. Int J Cardiol 2022; 359: 1-6. PMID: 35429510 116. Kim DW, Her SH, Ahn Y, et al. Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis. Int J Cardiol 2018; 252: 6-12. PMID: 29249438 117. Reis SE, Holubkov R, Conrad Smith AJ, et al. WISE Investigators. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 2001; 141: 735-741. PMID: 11320360 118. Lerman A, Sopko G. Women and cardiovascular heart disease: clinical implications from the Women’s Ischemia Syndrome Evaluation (WISE) Study. Are we smarter? J Am Coll Cardiol 2006; 47 Suppl: S59-S62. PMID: 16458173 119. Aziz A, Hansen HS, Sechtem U, et al. Sex-related differences in vasomotor function in patients with angina and unobstructed coronary arteries. J Am Coll Cardiol 2017; 70: 2349-2358. PMID: 29096805 120. Crea F, Bairey Merz CN, Beltrame JF, et al. Coronary Vasomotion Disorders International Study Group (COVADIS). The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. Eur Heart J 2017; 38: 473-477. PMID: 27907892 121. Dryer K, Gajjar M, Narang N, et al. Coronary microvascular dysfunc-